Engineered cell therapy for sustained local myocardial delivery of nonsecreted proteins

Cell Transplantation

Volumn 15, Issue 1, 2006, Pages 67-74

  Bian, Jing ^a,b   Kiedrowski, Matt ^b   Mal, Niladri ^b   Forudi, Farhad ^b   Penn, Marc S ^a,b  

^a Cleveland State University   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cell based therapy; Intercellular trafficking; Protein delivery; VP22

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN VP22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOGRAFT; CELL TRANSPLANTATION; COCULTURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE MODEL; ENDOTHELIUM; EVALUATION; FIBROBLAST; HEART MUSCLE CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; RAT STRAIN; SMOOTH MUSCLE FIBER; STEADY STATE;

ANIMALIA; HUMAN HERPESVIRUS 1; MAMMALIA;

EID: 33645664820     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783982197     Document Type: Article

References (30)

1. Askari, A.; Unzek, S.; Goldman, C. K.; Ellis, S. G.; Thomas, J. D.; DiCorleto, P. E.; Topol, E. J.; Penn, M. S. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. J. Am. Coll. Cardiol. 43:1908-1914; 2004.
2. Askari, A. T.; Unzek, S.; Popovic, Z. B.; Goldman, C. K.; Forudi, F.; Kiedrowski, M.; Rovner, A.; Ellis, S. G.; Thomas, J. D.; DiCorleto, P. E.; Topol, E. J.; Penn, M. S. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362:697-670; 2003.
3. Cashman, S. M.; Sadowski, S. L.; Morris, D. J.; Frederick, J.; Kumar-Singh, R. Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors-implications for gene therapy. Mol. Ther. 8:813-823; 2002.
4. Caron, N. J.; Quenneville, S. P.; Tremblay, J. P. Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem. Biophys. Res. Commun. 319:12-20; 2004.
5. Derer, W.; Easwaran, H. P.; Knopf, C. W.; Leonhardt, H.; Cardoso, M. C. Direct protein transfer to terminally differentiated muscle cells. J. Mol. Med. 77:609-613; 1999.
6. Dilber, M. S.; Phelan, A.; Aints, A. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther. 6:12-21; 1999.
7. Elloitt, G.; O'Hare, P. Intercellular trafficking and protein delivery by a herpes virus structural protein. Cell 88:223-233; 1997.
8. Hattan, N.; Warltier, D.; Gu, W.; Kolz, C.; Chilian, W. M.; Weihrauch, D. Autologous vascular smooth muscle cell-based myocardial gene therapy to induce coronary collateral growth. Am. J. Physiol. Heart Circ. Physiol. 287:H488-493; 2004.
9. Isner, J. M. Myocardial gene therapy. Nature 415:234-239; 2002.
10. Jarver, P.; Langel, U. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov. Today 9:395-402; 2004.
11. Kawamoto, A.; Losordo, D. W.; Asahara, T. Transplantation of endothelial progenitor cells for therapeutic neovascularization. In: Kpshidze, N. N.; Serruys, P. W., eds. Handbook of cardiovascular cell transplantation. London: Martin Dunitz; 2004:31-41.
12. Kawamoto, A.; Gwon, H. C.; Iwaguro, H.; Yamaguchi, J. I.; Uchida, S.; Masuda, H.; Silver, M.; Ma, H.; Kearney, M.; Isner, J. M.; Ashanra, T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103:634-637; 2001.
13. Kretz, A.; Wybranietz, W. A.; Hermening, S.; Lauer, U. M.; Isenmann, S. HSV-1 VP22 augments adenoviral gene transfer to CNS neurons in the retina and striatum in vivo. Mol. Ther. 7:659-669; 2003.
14. Lai, Z., Han, I.; Zirzow, G.; Brady, R.; Reiser, J. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors. Proc. Natl. Acad. Soc. USA 97:11297-11302; 2000.
15. Lindgren, M.; Hallbrink, M.; Prochiantz, A.; Langel, U. Cell-penetrating peptides. Trends Pharmacol. Sci. 21:99-103; 2000.
16. Lundberg, M.; Wikstrom, S.; Johansson, M. Cell surface adherence and endocytosis of protein transduction domain. Mol. Ther. 8:143-150; 2003.
17. Melo, L. G.; Pachori, A. S.; Kong, D.; Gnecchi, M.; Wang, K.; Pratt, R. E.; Dzau, V. J. Gene and cell-based therapies for heart disease. FASEB J. 18:648-663; 2004.
18. Orlic, D.; Hill, J. M.; Arai, A. E. Stem cells for myocardial regeneration. Circ. Res. 91:92-102; 2002.
19. Penn, M. S.; Francis, G. S.; Ellis, S. G.; Young, J. B.; McCarthy, P. M.; Topol, E. J. Autologous cell transplantation for the treatment of damaged myocardium. Prog. Cardiovasc. Dis. 45:21-32; 2002.
20. Pfeifer, A.; Kessler, T.; Yang, M.; Baranov, E.; Kootstra, N.; Cheresh, D. A.; Hoffman, R. M.; Verma, I. M. Transduction of liver cells by lentiviral vectors: Analysis in living animals by fluorescence imaging. Mol. Ther. 3:319-322; 2001.
21. Phelan, A.; Elliott, G.; O'Hare, P. Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat. Biotechnol. 16:440-443; 1998.
22. Potapova, I.; Plotnikov, A.; Lu, Z.; Danilo, Jr., P.; Valiunas, V.; Qu, J.; Doronin, S.; Zuckerman, J.; Shlapakova, I. N.; Gao, J.; Pan, Z.; Herron, A. J.; Robinson, R. B.; Brink, P. R.; Rosen, M. R.; Cohen, I. S. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ. Res. 94:952-959; 2004.
23. Shen, H.; Mai, J. C.; Cao, S.; Robbins, P. D.; Cheng, T. Evaluation of peptide-mediated transduction in human CD34+ cells. Hum. Gene Ther. 15:415-419; 2004
24. Snyder, E. L.; Dowdy, S. F. Cell penetrating peptides in drug delivery. Pharm. Res. 21:389-393; 2004.
25. Stroh, C.; Held, J.; Samraj, A. K.; Schulze-Osthoff, K. Specific inhibition of transcription factor NF-κB through intracellular protein delivery of IκBα by the Herpes virus protein VP22. Oncogene 22:5367-5373; 2003.
26. Suzuki, K.; Murtuza, B.; Brand, N. J.; Varela-Carver, A.; Fukushima, F; Yacoub, M. H. Enhanced effect of myocardial gene transfection by VP22-mediated intercellular protein transport. J. Mol. Cell. Cardiol. 36:603-606; 2004.
27. Trehin, R.; Merkle, H. P. Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur. J. Pharm. Biopharm. 58:209-223; 2004.
28. Verma, I. M.; Somia, N. Gene therapy-promise, problems and prospects. Nature 389:239-242; 1997.
29. Zender, L.; Kock, R. Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors. Gastroentorology 123:608-618; 2002.
30. Zender, L.; Kuhnel, F.; Kock, R.; Manns, M.; Kubicka, S. VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo. Cancer Gene Ther. 9:489-496; 2002.